Skip to main content
S 2586 118th Congress Senate Health

Drug Shortages Prevention and Quality Improvement Act

Introduced: July 27, 2023 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 27, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jul 27, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Drug Shortages Prevention and Quality Improvement Act

This bill establishes several programs and requirements to address potential shortages of critical drugs.

For example, the bill requires manufacturers of life-saving drugs to submit data to the Food and Drug Administration (FDA) to help determine the longest possible expiration dates for these drugs. Manufacturers must also notify the FDA of any increased demand for life-saving drugs that could lead to shortages. Manufacturers are subject to civil penalties for violations.

The bill also (1) establishes a grant program to support advanced manufacturing of essential sterile injectable drugs that are vulnerable to shortages, and (2) requires the Government Accountability Office to study the extent of recent shortages of drugs for which payment is made to hospitals under Medicare and whether payment changes could minimize shortages.

What's happening now July 27, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 5

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 2
All 2 Democratic 2
D
Blumenthal, Richard
Connecticut · Jul 27, 2023
 D
Smith, Tina
Minnesota · Jul 27, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2586: Drug Shortages Prevention and Quality Improvement Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2586/
MLA
"S. 2586: Drug Shortages Prevention and Quality Improvement Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2586/.
Bluebook (legal)
S. 2586, 118th Cong. (2026), https://openamerica.io/bill/118-S-2586/.
Markdown link
[S. 2586: Drug Shortages Prevention and Quality Improvement Act](https://openamerica.io/bill/118-S-2586/)
Report a problem